To further characterize protective-type (IgG1/IgG3) antibody responses to Plasmodium falciparum blood stage in putatively immune individuals' plasma, we have tested for various analogs of the 19 kDa C-terminus of the MSP1 antigen obtained as secreted recombinant proteins from Saccharomyces cerevisiae. One of four proteins was then identified on the basis of consistent IgG3, along with less variable IgG1 recognition. This protein has thus been selected for further functional assays of IgG1/IgG3 antibodies.
The mechanisms for antibodies (Abs) in mediating protection to asexual blood stage Plasmodium falciparum parasite development presumably involve cytophilic type Abs of the IgG1 and IgG3 subclasses, and IgG2 and IgG4 would act as antagonists. [1] [2] [3] However, there are still many gaps in the detailed understanding of how natural protection is acquired and maintained in endemic areas. To identify mechanisms leading to the selection of specific responses of a given Ab class/subclass would be of interest to target the desired subclass production for Abs specific to ''protective'' epitopes in P. falciparum blood stage antigens (Ags) selected to serve as vaccine candidates.
To further characterize Ags which are consistently associated with cytophilic, protective-type IgG1/IgG3 Abs, we have tested plasma obtained from a number of putatively immune Senegalese adults, originating from the villages of Dielmo where P. falciparum transmission is intense and perennial or Ndiop where transmission is low to moderate and seasonal. 4, 5 The individuals' characteristics have been described previously, along with data showing that approximately two-thirds of them had specific Abs to MSP1 19 . [6] [7] [8] is regarded as a foremost vaccine candidate generally associated with clinical immunity to P. falciparum. [9] [10] [11] Anti-MSP1 19 Abs in the study population were mostly restricted to IgG1 and IgG3 isotypes with virtually no specific IgG2 and IgG4. 6 We have thus chosen to restrict the present study to MSP1 19 and we have tested for 4 analogs of this protein.
For the present study, blood sampling and processing were done exactly as described. 6 There were two different periods of sampling: in June, when P. falciparum transmission was moderate (Dielmo) or virtually absent (Ndiop) and in January, following the rainy season when P. falciparum transmission was maximum. 4,5 MSP1 19 was obtained as secreted recombinant proteins from Saccharomyces cerevisiae and purified as described. 12 Four analogs corresponding to amino-acid variations in the first (Q versus E) and second (KNG versus TSR) EGF-like motifs of MSP1 19 were obtained using similar procedures, namely Q-KNG, Q-TSR, E-KNG, and E-TSR. 12 The concentration of the four recombinant proteins were adjusted to 1 mg/mL as measured by BCA (Pierce, Rockford, IL) and subsequently diluted for enzyme linked immunosorbent assays (ELISA). ELISA procedures were performed exactly as previously described with mouse antihuman IgG subclass Abs (Bionostics, Wyboston, Beds, UK) diluted 1:10,000 to 1:20,000 as appropriate. 6 To minimize plate-to-plate and day-to-day variations, data were recorded as optical density values (OD). OD ratios Ͼ 1.5 were defined as positive responses which basically correspond to the mean Ϯ 3 Standard Errors to the Mean (SEM). 6 The Fisher's exact test was used to compare groups ( 2 ).
Individual responses are shown in Figure 1 . The difference in the frequency of IgG1 responses was not statistically significant among the four analogs although the response was slightly higher for Q-KNG (global test: 2 ϭ 2; P ϭ 0.57); in contrast, a significant difference was seen within IgG3 responses (global test: 2 ϭ 8.28; P ϭ 0.01). IgG3 responses to Q-KNG were significantly different from those to Q-TSR and E-TSR (P ϭ 0.016 and P ϭ 0.005, respectively) and more frequent than those to E-KNG, though not significant (P ϭ 0.13). Because the cohort was being constituted over two consecutive years (1996 and 1997), we ascertained that the frequencies of responses from each year could be legitimately combined in the analyses. As the proportion of ''responders'' versus ''non-responders'' in Dielmo and in Ndiop did not significantly differ from Year 1 to Year 2 (P values ranging from 0.35 to 0.91), data from Years 1 and 2 were subsequently considered together in each village and for each season. The comparison of IgG1 or IgG3 responses to all four yPfMSP1 19 analogs was not significantly affected by analyzing data site by site or season by season (P ranging from 0.16 to 1.0). Of note, neither anti-MSP1 19specific IgG2/IgG4 was found in the present study.
An imbalance in IgG subclass distribution in Abs to P. falciparum blood stage Ags has been widely reported. [1] [2] [3] In fact, protection against this stage seems to rely largely on specific IgG1 and IgG3 Abs, whose ratio (IgG1/IgG3) depends on the Ag used in the isotype-specific immunoassay. 1, 13, 14 Unlike other asexual blood stage Ags, MSP1 19 seems to elicit a restricted set of Ab responses in immune populations, with elevated IgG1/IgG3 and little if any IgG2 and IgG4; the yPfMSP1 19 -Q-KNG proved to be optimally recognized by IgG1 and IgG3 in plasma from the selected study population. This suggests that subclass-specific responses can be influenced by the epitope they recognize and that certain measures of anti-MSP1 19 IgG3 might have been Individual responses for all four analogs and for the two IgG sub-underestimated in different studies (herein, several IgG3, unlike IgG1, responses were ranging from OD ratios Ն 1.5 but Ͻ 2).
Of particular note in the present analysis was the observation that if an individual's plasma was positive for an IgG1 or IgG3 response to the Q-TSR, E-TSR, or E-KNG analogs then that individual's sample was also positive for Q-KNG, without exception (Figure 1 ). From this, it can be concluded that in putative immune individuals subjected to epidemiological situations comparable to either Dielmo or Ndiop (which might not be the case in different transmission conditions or in other age groups), anti-Q-KNG-MSP1 19 IgG1/ IgG3 responses can be used as a surrogate of positive IgG1/ IgG3 responses to the other yPfMSP1 19 analogs. This provides a useful tool to further dissect the evolution of specific IgG1/IgG3 responses over time and the dynamics of the production and use of such Abs, a requisite for the examination of conditions which account for the maintenance of protective immunity to P. falciparum blood stages.
